A wheat germ cell-free expression plasmid of the Biotin-tagged NLRP3 protein.
Clone info. | A wheat germ cell-free expression plasmid of the Biotin-tagged Nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 (NLRP3) protein (biotin ligation site (Bls) amino acid sequence: GLNDIFEAQKIEWHE). In cell-free reconstituted NLRP3 innflammasome system, the purified product can be a donor of amplified luminescence proximity homogeneous assay (ALPHA) process in vitro. See the NLRP3-FL-Btn protein construct at Fig. 1 in Kaneko, N. et al. Sci. Rep. 10 (1): 13562, 2020. |
---|---|
Comment | If you use a QIAGEN kit, it is recommended that you use the Plasmid Midi or Maxi Kit. The use of miniprep kits, including products from other companies, is not recommended. Expression was confirmed by the depositor with western blotting. |
Vector backbone | pEU-E01-GW-Bls (plasmid) |
Size of vector backbone | 5.0 kb |
Selectable markers | Ampicillin |
Growth remarks | Stbl2 is recommended E. coli for plamid amplication. |
Gene/insert name | human NLRP3 cDNA |
Depositor|Developer | Masumoto, Junya | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | In publishing the research results obtained by use of the BIOLOGICAL RESOURCE, a citation of literature designated by the DEPOSITOR is requested. (Kaneko, N. et al., Sci. Rep. 10 (1): 13562, 2020) |
Remarks | Gateway® Expression clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 利用者は、研究成果の公表にあたって寄託者の指定する文献を引用する(Kaneko, N. et al., Sci. Rep. 10 (1): 13562, 2020)。 |
備考 | Gateway®テクノロジーを用いた発現クローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。 |
Catalog # | Resource name | Availability | Shipping form | Fee (non-profit org.) |
---|---|---|---|---|
RDB19445 | pEU-E01-NLRP3-FL-Bls | Under QC test. Please contact us. | DNA solution |
Materials & Methods section:
The pEU-E01-NLRP3-FL-Bls was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB19445). |
Reference section:
Kaneko, N., Kurata, M., Yamamoto, T., Shigemura, T., Agematsu, K., Yamazaki, T., Takeda, H., Sawasaki, T., Koga, T., Kawakami, A., Yachie, A., Migita, K., Yoshiura, K.I., Urano, T., Masumoto, J., KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle-Wells syndrome. Sci. Rep. 10 (1): 13562 (2020). PMID 32782316. [link to RRC of NBRP] |
Further references such as user reports and related articles (go to bottom)
Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.
Original, user report and related articles
original | Kaneko, N., KN3014, a piperidine-containing small compound, inhibits auto-secretion of IL-1β from PBMCs in a patient with Muckle-Wells syndrome. Sci. Rep. 10 (1): 13562 (2020). PMID 32782316. [link to RRC of NBRP] |
---|---|
reference | Kaneko, N., Poly (I:C) and hyaluronic acid directly interact with NLRP3, resulting in the assembly of NLRP3 and ASC in a cell-free system. Eur. J. Inflamm. 15 (2): 85-97 (2017). |
Featured content